Improving Vitamin D Levels with Different Treatments
Different Kinds of Vitamin D Intake and Its Metabolites: Blood Levels and Bone Mineral Density. A Randomized Clinical Trial.
This study is testing which of two types of Vitamin D supplements works best for people with low Vitamin D levels to help improve their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari Academic / other |
| Locations | 1 site (Bari) |
| Trial ID | NCT06138249 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of two forms of Vitamin D supplementation, Calcifediol and Cholecalciferol, in patients suffering from hypovitaminosis D. Participants are randomly assigned to one of three treatment groups: one receiving Calcifediol monthly, another receiving Cholecalciferol bi-weekly, and a third receiving daily Calcifediol drops. After one month of treatment, serum levels of Vitamin D will be measured to determine the most effective dosage. The study aims to optimize Vitamin D intake for better health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with hypovitaminosis D, characterized by serum levels below 20 ng/mL.
Not a fit: Patients with osteoporosis or those suffering from renal or hepatic diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved Vitamin D levels in patients, enhancing their overall health and well-being.
How similar studies have performed: Other studies have shown varying success with Vitamin D supplementation, but this specific comparison of Calcifediol and Cholecalciferol is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hypovitaminosis D (\<20ng/mL) Exclusion Criteria: * Osteoporosis (T score \<-2.5SD) * Renal or hepatic diseases
Where this trial is running
Bari
- University of Bari — Bari, Italy (Recruiting)
Study contacts
- Study coordinator: Silvana De Giorgi, AP
- Email: silvana.degiorgi@uniba.it
- Phone: 3389821930
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.